The site navigation utilizes arrow, enter, escape, and space bar key commands. Left and right arrows move across top level links and expand / close menus in sub levels. Up and Down arrows will open main level menus and toggle through sub tier links. Enter and space open menus and escape closes them as well. Tab will move on to the next part of the site rather than go through menu items.
In hospitals across the country, life-saving medical devices hum along, year after year. Many of these machines have been trusted companions for more than a decade—reliable, familiar and, in some cases, irreplaceable. But beneath that reliability can lie hidden danger.
Battelle has developed a new polymer nanoparticle (PNP) delivery system that can target specific cell types, such as neuronal cells. The work, which was recently recognized as the “Best Poster” at the Controlled Release Society 2024 Annual Meeting in Italy, could pave the way for safer, more effective gene therapies for genetic diseases.
As the hospital-at-home (HaH) movement gains momentum, we’re witnessing a transformation in how and where care is delivered. Medical devices, once exclusive to hospitals are now being adapted for home use.
Restoring movement for people who live with paralysis has been a research imperative at Battelle since the early 2000s. Today this goal is closer than ever.
From concept innovation and human centric design of new products, to device commercialization, and more, Battelle forges the path for medical device development.
Follow along with the latest news, announcement and updates from our Battelle community of solvers.
We use cookies to personalize content and ads, to provide social media features and to analyze our traffic. We also share information about your use of our site with our social media, advertising and analytics partners. By continuing to browse our
site without changing your settings, you are agreeing to accept all cookies on the site.
